Implant

Family Dentistry of Frisco Introduces Advanced Dental Implant Solutions with Innovative PRP Technique and Comprehensive Sedation Options

Retrieved on: 
Mercredi, mars 6, 2024
Regeneration, DDS, Multimedia, Dentures, Nitrous oxide, Platelet, Dental implant, Quality of life, Overalls, Platelet-rich plasma, Dental, Dental care, Safety, PRP, Patient, Anatomy, Dentistry, Implant

FRISCO, Texas, March 5, 2024 /PRNewswire-PRWeb/ -- Family Dentistry of Frisco, under the esteemed leadership of Dr. Paresh B. Patel, DDS, is proud to announce the expansion of its dental services to include state-of-the-art Dental Implants and Implant Supported Dentures, commonly referred to as All-on-4. These advanced treatments are now enhanced by the innovative use of Platelet-Rich Plasma (PRP) technology, setting a new standard in dental care excellence and patient comfort in the Frisco area.

Key Points: 
  • Family Dentistry of Frisco has proudly announced the introduction of its advanced dental implant solutions, featuring the innovative Platelet-Rich Plasma (PRP) technique and a wide range of comprehensive sedation options.
  • At the forefront of dental technology, Family Dentistry of Frisco incorporates PRP in implant procedures to accelerate healing and improve the success rate of dental implants.
  • Understanding the importance of comfort and ease for our patients, Family Dentistry of Frisco offers multiple levels of sedation dentistry to ensure a calm and pain-free experience during dental implant procedures.
  • The introduction of PRP technology and our comprehensive sedation options exemplify our commitment to pioneering dental treatments that prioritize patient well-being and satisfaction."

ZimVie Announces Launch of Next-Generation TSX® Implant in Japan

Retrieved on: 
Mercredi, février 7, 2024
DTI, TSX, SVP, Implant, Osseointegration, Medical device

WESTMINSTER, Colo., Feb. 07, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the launch of the TSX® Implant in Japan.

Key Points: 
  • WESTMINSTER, Colo., Feb. 07, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the launch of the TSX® Implant in Japan.
  • As ZimVie’s largest dental implant market in APAC and fifth largest market globally, Japan is of great strategic importance to ZimVie.
  • The launch of TSX in Japan allows the company to compete head-to-head with premium market leaders in the dental implant space.
  • “We’re excited to expand our TSX Implant line globally, with the offering now available in Japan,” said Indraneel Kanaglekar, SVP and President of ZimVie Dental.

Advanced Orthopedic Technologies, Implants and Regenerative Products Market Outlook Report to 2027 - A $84.8 Billion Market by 2027 - ResearchAndMarkets.com

Retrieved on: 
Mercredi, décembre 27, 2023
Medical Supplies, Health, Medical Devices, Biometrics, Hospitals, Surgery, Biotechnology, Geography, Stryker Corporation, Regeneration, Medtronic, Cartilage, Organization, Implant, Medical device

The "Advanced Orthopedic Technologies, Implants and Regenerative Products" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Advanced Orthopedic Technologies, Implants and Regenerative Products" report has been added to ResearchAndMarkets.com's offering.
  • The global market for advanced orthopedic technologies, implants, and regenerative products was valued at $63.3 billion in 2022.
  • The market is forecast to grow at a compound annual growth rate (CAGR) of 4.1% to reach $84.8 billion in 2027.
  • The report is segmented based on device types such as bone repair and regenerative products, cartilage and soft tissue repair, regenerative products, and joint replacement, implants, and regenerative products.

Affordable Care Announces New Chief Clinical Officers for Affordable Dentures & Implants

Retrieved on: 
Mercredi, novembre 8, 2023
University, Howard University College of Dentistry, Dental education throughout the world, Columbia University School of Nursing, DDS, Health, Dentistry, College, Growth, Clark Atlanta University, Nova Southeastern University College of Pharmacy, Columbia University, DMD, Rural Health Workforce and The Patient Protection and Affordable Care Act, Nursing, Implant

RALEIGH, N.C., Nov. 8, 2023 /PRNewswire/ -- Today, Affordable Care announced that Jumoke Adedoyin, DDS, MICOI, MAAIP, AFAAID, and Daniel Fenton, DMD, FAGD, AFAAID, DICOI, have been named Chief Clinical Officers of Affordable Dentures & Implants , the nation's largest provider network of dental practices -- supported by Affordable Care – that are solely focused on tooth replacement services.

Key Points: 
  • RALEIGH, N.C., Nov. 8, 2023 /PRNewswire/ -- Today, Affordable Care announced that Jumoke Adedoyin, DDS, MICOI, MAAIP, AFAAID, and Daniel Fenton, DMD, FAGD, AFAAID, DICOI, have been named Chief Clinical Officers of Affordable Dentures & Implants , the nation's largest provider network of dental practices -- supported by Affordable Care – that are solely focused on tooth replacement services.
  • "Dr. Adedoyin and Dr. Fenton have been instrumental in advancing clinical education, doctor mentorship and engagement, product innovation and best practice sharing across the Affordable Dentures & Implants supported practice network," explains Will Johnson, Chief Operating Officer, Affordable Care.
  • Dr. Adedoyin most recently served as the Director of Clinical Relations for Affordable Dentures & Implants and has been a practice owner within the network for nearly 15 years.
  • Dr. Fenton, a practice owner since 2013, has served as Affordable Dentures & Implants' Director of Clinical Education & Training.

Dr. Irfan Atcha gets invited to the exclusive 3D Full Arch Advisory Board VIP Event in Los Angeles, CA

Retrieved on: 
Samedi, septembre 30, 2023
Well, International Congress of Oral Implantologists, 3D, The Langham Huntington, Pasadena, Maintenance, Implant, KOL, Dentist, Patient, Dentistry

CHICAGO, Sept. 29, 2023 /PRNewswire-PRWeb/ -- Well established Full arch Dental Implant Center like New Teeth Chicago Dental and experienced Implant Surgeons like Dr. Irfan Atcha utilized office dental 3D printing and works with Sprint Ray as their technology partners. This helps improve the efficiency of forward-thinking practices all over the world. By leveraging existing technologies that exist in digital dentistry, 3D printing enables better outcomes to patient needs, significantly reduces manufacturing times, and opens up new treatment options. With low operating costs, minimal maintenance, and user-friendly design, SprintRay is the choice of 3D printer for all the patients need at New Teeth Chicago Dental.

Key Points: 
  • 3DX is an invite-only advisory board meeting featuring top dentists and Implant specialists from around the US to discuss the future of digital full arch dentistry.
  • CHICAGO, Sept. 29, 2023 /PRNewswire-PRWeb/ -- Well established Full arch Dental Implant Center like New Teeth Chicago Dental and experienced Implant Surgeons like Dr. Irfan Atcha utilized office dental 3D printing and works with Sprint Ray as their technology partners.
  • The exclusive event being held at the The Langham Huntington, Pasadena CA is limited to top 35 VIP guests Key opinion leaders (KOL) such as Dr. Atcha who are experienced Implantologists with leading Dental Implant Centers across the US.
  • This event will also allow collaboration and synergize all like minded full arch dental implant specialists under one roof.

Implants like pacemakers and insulin pumps often fail because of immune attacks − stopping them could make medical devices safer and longer-lasting

Retrieved on: 
Lundi, septembre 25, 2023
Infection, Tissue, Nature Biomedical Engineering, RAC2, Polymer, Implant failure, Research, Cell, Biomaterial, Pain, Implant, Capsule, Protein, Patient, Risk, Nervous system, Immune system, Breast, Mouse, Collagen, Safety, Injury, Mechanics, Medical device, Silk, Vaccine

However, many implants fail because the body rejects them, and they need to be removed because they no longer function and can cause pain or discomfort.

Key Points: 
  • However, many implants fail because the body rejects them, and they need to be removed because they no longer function and can cause pain or discomfort.
  • Developing treatments that target the mechanisms driving foreign body responses could improve the design and safety of biomedical implants.

Mechanics of implant rejection

    • Researchers hypothesize that foreign body responses are triggered by the chemical and material composition of the implant.
    • Immune cells activated by mechanical pressure respond by building a capsule made of scar tissue around the implant in an attempt to shield it off.
    • Some people have very strong reactions that result in a large, thick capsule that constricts around the implant, impeding its function and causing pain.
    • These findings suggest that activating mechanical stress pathways triggers immune cells with RAC2 to generate severe foreign body responses.

Developing new treatments

    • My colleagues and I believe that treatments that target the pathways associated with RAC2 could potentially mitigate or prevent free body responses.
    • A complete understanding of the molecular mechanisms driving foreign body responses would be the final frontier in developing truly bio-integrative medical devices that could integrate with the body with no problems for the recipient’s entire life span.

Peptilogics Reports Positive 180-Day Top-Line Interim Data From Phase 1B Trial of PLG0206 in Patients With Periprosthetic Joint Infection (PJI)

Retrieved on: 
Mardi, septembre 19, 2023
Biotechnology, FDA, Other Health, Health, Clinical Trials, Infection, CARB-X, Obesity, Surgeon, Biomedical Advanced Research and Development Authority, Failure, Prevalence, Diabetes, Aftercare, Use of Free and Open-Source Software (FOSS) in the U.S. Department of Defense, Human services, Office of Inspector General, U.S. Department of Health and Human Services, Wellcome Trust, Overalls, Administration for Strategic Preparedness and Response, Quality of life, Risk, AMR, Implant, Administration, Development, Journal, TKA, Patient, Thomas Jefferson University Hospital, Low-dose naltrexone, UPMC, Debridement, Research, Orthopedic surgery, Recurrence, Biofilm, Pharmaceutical industry, Arthroplasty

Peptilogics, a clinical-stage biotechnology company, today announced new top-line interim data for PLG0206 in periprosthetic joint infection (PJI) patients from their ongoing Phase 1b trial.

Key Points: 
  • Peptilogics, a clinical-stage biotechnology company, today announced new top-line interim data for PLG0206 in periprosthetic joint infection (PJI) patients from their ongoing Phase 1b trial.
  • At 180-days following treatment with PLG0206 administered during a DAIR (Debridement, Antibiotics, and Implant Retention) surgery, no treatment-related serious adverse events were reported in either cohort.
  • One recurrence was observed in the trial (one of 14 patients, 7%), which was in the Low Dose cohort at Day-180; no recurrences were observed in the High-Dose cohort.
  • “Most of the patients in this trial have a very high risk of failure due to their comorbidities including obesity, diabetes, and prior joint surgeries, making them some of the hardest patients to treat.

Enhancing Patient Outcomes: Surge in Breast Reconstruction Drives Growth of Global Reconstruction Meshes Market to 2033 - ResearchAndMarkets.com

Retrieved on: 
Mercredi, septembre 6, 2023
Biotechnology, Health, Surgery, Tissue, ASP, Patient satisfaction, Internet, COVID-19, Market access, Country, CMO, Strategic planning, Implant, SWOT, Mastectomy, Investment, Reading, SWOT analysis, Breast, Growth, Region, Epidemiology, LIBOR market model, Pelvic organ prolapse, General surgery, Forecast, Safety, Breast reconstruction, Urinary incontinence, Retail, Medical imaging, Health care, Risk management

The model discusses in detail the impact of COVID-19 on Reconstruction Meshes market for the year 2020 and beyond.

Key Points: 
  • The model discusses in detail the impact of COVID-19 on Reconstruction Meshes market for the year 2020 and beyond.
  • The breast reconstruction market is increasing dramatically due to improvements in patient satisfaction, reduced costs, and decreases in side-effects from procedures.
  • Use of repair meshes along with breast implants is emerging as an effective method for breast reconstruction after mastectomy.
  • Global, Regional and Country level market specific insights:
    Qualitative market specific information is available with global trends further broken down into regional trends.

4D printing in healthcare market size to Grow by USD 42,391.26 thousand from 2022 to 2027 | The increased demand for personalized or customized medical devices to boost market growth - Technavio

Retrieved on: 
Jeudi, août 24, 2023
Equipment, Component, Medicine, Challenge, Elective surgery, Health care, Software, Research, Instrument, USD, Patient, ROW, Implant, 3D Systems, Growth, Otto GmbH, MAI Systems Corp. v. Peak Computer, Inc., 3D printing, Retail, Medical device, Geography

The size of the market is forecast to increase by USD 42,391.26 thousand according to Technavio.

Key Points: 
  • The size of the market is forecast to increase by USD 42,391.26 thousand according to Technavio.
  • The increased demand for personalized or customized medical devices is the key factor notably driving market growth.
  • The growing demand for personalized or customized medical devices is driving the growth of the market in particular.
  • Significant Challenge - The high initial setup cost of 4D printing facilities is a challenge that affects the growth of the market.

Global Medical Plastics Market Report 2023: Sector is Expected to Reach $54.28 Billion by 2028 - ResearchAndMarkets.com

Retrieved on: 
Mardi, juillet 4, 2023
Medical Supplies, Health, Heart, Plastic, Engineering, Polyvinyl chloride, Association for the Advancement of Medical Instrumentation, Polymer, Biometrics, Catheter, Sterilization, Mask, Application, PP, Implant, Growth, Digital, AI, Bandage, PVC, Syringe, Medical device, Polyethylene

During the forecasted period of 2023-2028, polypropylene is the fastest growing segment in medical plastics.

Key Points: 
  • During the forecasted period of 2023-2028, polypropylene is the fastest growing segment in medical plastics.
  • By Application: The report provides the medical plastics market analysis based on application: Medical Disposals, Drugs Packaging, Medical Instruments, Prosthetics and Implants and Others.
  • In 2022, North America dominates the global medical plastics market, driven by rise in geriatric population and the increasing demand for home healthcare services.
  • Asia Pacific is anticipated to be the fastest growing region in the medical plastics market.